Future research into non-Hodgkin lymphoma treatments needs to explore long-term outcomes and a better understanding biologic ...

Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address ...

Q1 2025 Earnings Call Transcript May 8, 2025 Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...

Abstract: Cancer of the lung system is arguably the second largest factor in the worldwide fatality explosion. It originates from smoking too much and tobacco use. Uncontrolled cell growth in the lung ...

An investigational viral immunotherapy extended survival compared with standard care for patients with advanced non-small cell lung cancer who had inadequate response to immune checkpoint inhibitor ...

Panelists discuss how the 5-year CROWN trial data for lorlatinib have shaped the treatment paradigm for ALK+ metastatic ...

The potential of computational chemistry to revolutionise cancer treatment in Nigeria represents a paradigm shift in medical ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

Clemo said. In 2022, the cause hit closer to home than she ever thought possible when her mom was diagnosed with stage four lung cancer. Clemo said since her mom has never smoked, the diagnosis ...

Though the spot was very small, further tests, including a biopsy, identified stage 1 adenocarcinoma, a non-small cell lung cancer, and one of the most common primary lung cancers. “I lost it. I was ...

Wang and his collaborators developed cell lines derived from patients with small cell lung cancer. When BRDT was suppressed in lung cancer cells, it significantly slowed tumor progression and ...